Markov Biosciences Analysis: $300K Raised
What is Markov Biosciences?
Markov Biosciences specializes in interpretable biological simulators that accelerate early-stage therapeutics discovery. Their unique approach combines machine learning with extensive biological data to create virtual cell models. This innovation enables research teams to efficiently identify therapeutics for clinical advancement.
Employees
1-10
Founded
2023
Industry
AI/ML, Biotech
Product Features & Capabilities
- Interpretable virtual cell models trained on ‘omics data
- Tools for introspection and natural language probing
- Simulators supporting all biological modalities
- Spatial and temporal simulation capabilities
- In silico perturbation experiments with various therapeutic modalities
Use Cases
Accelerate the design of wet-lab experiments; Analyze biological data through interpretable models; Simulate complex biological systems in silico; Optimize therapeutic discovery processes; Conduct virtual experiments with diverse modalities
How much Markov Biosciences raised
Pre-Seed - $300,000
2 years agoLead Investor: Long Journey Ventures
See something that needs updating? Suggest edits to this profile.
